期刊文献+

血管生成素2与腹膜透析时腹膜血管新生的关系 被引量:3

Association of peritoneal angiogenesis with angiopoietin-2 in peritoneal dialysis rats
原文传递
导出
摘要 目的观察血管生成素2(Angpt-2)和腹膜透析(腹透)时腹膜血管新生的关系。方法5/6肾切除制作尿毒症大鼠模型,成模后在腹腔内植入腹透管,根据大鼠体质量每天经腹透管注入定量腹透液(4.25%,Dineal)。按腹透时间分为未腹透组、腹透10d组、28d组及56d组。假手术非尿毒症非透析大鼠为对照组。大网膜抗CD31免疫组化染色后作血管计数,观察腹膜血管新生。用实时定量PCR和Western印迹分别检测腹膜Angpt-2和血管内皮生长因子(VEGF)表达量变化,同时检测腹膜血管数和Angpt-2、VEGF表达量的关系。结果未腹透组、腹透10d、28d及56d组腹膜血管数显著高于对照组[(5±3)、(10±5)、(17±5)及(19±4)比(1±1)个/HP,均P〈0.051。腹透28d组腹膜血管数显著高于腹透10d组(P〈0.05),但与56d组差异无统计学意义。未腹透组或腹透各组腹膜Angpt-2和VEGF表达显著高于对照组(均P〈0.01),而Angpt-2和VEGF表达量并未随透析时间延长而增加。Angpt-2和VEGF表达量和腹膜血管数呈正相关(r=0.7756,P〈0.01;r=0.5223,P〈0.05)。结论尿毒症状态和腹透促进腹膜血管新生。腹膜Angpt-2表达增加和腹膜血管新生呈正相关。Angpt-2将可能成为治疗腹膜血管新生的另一靶点。 Objective To investigate the association between angiopoietin-2 (Angpt-2) and peritoneal angiogenesis in a uremic peritoneal dialysis (PD) rat model. Methods Uremic (subtotal nephrectomy) rats were established and divided into non-PD, 10 d-PD, 28 d-PD and 56 d-PD groups. Standard PD solution was applied in the study. Rats undergone sham operation without PD were used as control group. Vessel density of the peritoneum was detected and quantified with anti-CD31 immunohistochemical staining. Expressive levels of Angpt-2 and vascular endothelial growth factor (VEGF) were examined in the peritoneum by real-time PCR and Western blotting. Results The non-PD group was characterized by increased vessel density in the peritoneum compared with that of the control group [(5+3)/HP vs (1+1)/HP]. Progressive angiogenesis was found in 10 d-PD, 28 d-PD and 56 d-PD groups [( 10+5 )/HP, (17+5)/HP, (19+ 4)/HP]. Furthermore, expressive levels of Angpt-2 and VEGF increased significantly in the non-PD group compared with the control (P〈0.01), and such expressions were significantly higher in the PD groups as compared to non-PD group (P〈0.01), but no difference was found among the PD groups. Both VEGF and Angpt-2 levels were positively correlated with vessel density(r=0.7756, P〈 0.01; r=0.5223, P〈0.05). Conclusions Uremia and PD promote peritoneal angiogenesis in rats. Increased expression level of Angpt-2 in peritoneum is positively correlated with peritoneal angiogenesis. Angpt-2 may be a new therapeutic target of peritoneal angiogenesis.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2009年第6期415-419,共5页 Chinese Journal of Nephrology
基金 上海市科委课题基金(044119620,177QA14040,08dz1900501)
关键词 腹膜透析 新生血管化 病理性 血管生成素2 血管内皮生长因子 Peritoneal dialysis Neovascularization, pathologic Angiopoietin-2 Vascular endothelial growth factor
  • 相关文献

参考文献16

  • 1Saxena R. Pathogenesis and treatment of peritoneal membrane failure. Pediatr Nephrol, 2008, 23: 695-703.
  • 2Lopez-Cabrera M, Aguilera A, Aroeira LS, et al. Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure. Perit Dial Int, 2006, 26: 26-34.
  • 3Siemeister G, Schimer M, Weindel K, et al. Two independent mechanisms essential for tumor angiogenesis:inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway. Cancer Res, 1999, 59: 3185-3191.
  • 4Takagi H, Koyama S, Seike H, et al. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization. Invest Ophthalmol Vis Sci, 2003, 44: 393 -402.
  • 5Eggert A, Ikegaki N, Kwiatkowski J, et al. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin Cancer Res, 2000, 6: 1900-1908.
  • 6Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol, 1995, 147: 9-19.
  • 7Zareie M, De Vriese AS, Hekking LH, et al. Immunopathological changes in a uraemic rat model for peritoneal dialysis. Nephrol Dial Transplant, 2005, 20: 1350-1361.
  • 8Nob H, Kim JS, Han KH, et al. Oxidative stress during peritoneal dialysis: implications in functional and structural changes in the membrane. Kidney Int, 2006, 69: 2022- 2028.
  • 9Rumpsfeld M, McDonald SP, Johnson DW. Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol, 2006, 17: 271-278.
  • 10Krediet RT. Peritoneal physiology-impact on solute and fluid clearance. Adv Ren Replace Ther, 2000, 7: 271-279.

同被引文献24

  • 1张晓东,钱家麒.一种简便的正常大鼠腹膜透析模型建立[J].中国血液净化,2005,4(6):326-328. 被引量:9
  • 2于青,赵东杰,徐琦,姚建.高糖、尿毒症血清对人腹膜间皮细胞VEGF表达的影响[J].中国血液净化,2005,4(7):379-380. 被引量:4
  • 3袁江姿,钱家麒,方炜,倪兆慧,戴慧莉.可溶性酪氨酸激酶2融合蛋白对肿瘤坏死因子α诱导腹膜血管内皮细胞新生血管能力的影响[J].中华肾脏病杂志,2007,23(7):453-457. 被引量:3
  • 4Margetts PJ,Gyorffy S,Kolb M,et al.Antiangiogenic and antifibroticgene therapy in a chronic infusion model of peritoneal dialysis in rats.J Am Soc Nephrol,2002,13:721-728.
  • 5Bellini MH,Coutinho EL,Filgueiras TC,et al.Endostatin expression in the murine model of ischaemia/reperfusioninduced acute renal failure.Nephrology (Carlton),2007,12:459 -465.
  • 6Weidner N.Intratumor microvessel density as prognostic factor in cancer.Am J Pathol,1995,147:9-19.
  • 7Zareie M,De Vriese AS,Hekking LH,et al.Immunopathological changes in a uraemic rat model for peritoneal dialysis.Nephrol Dial Transplant,2005,20:1350-1361.
  • 8Van Westrhenen R,Zweers MM,Kunne C,et al.A pyruvate-buffered dialysis fluid induces less peritoneal angiogenesis and fibrosis than a conventional solution.Perit Dial Int,2008,28:487-496.
  • 9Parikova A,Smit W,Struijk DG,et al.Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure.Kidney Int,2006,70:1988-1994.
  • 10Margetts PJ,Gyorffy S,Kolb M,et al.Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats.J Am Soc Nephrol,2002,13:721-728.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部